[3576] Hohman, T. J., Koran M E. I., Thornton-Wells T. A., & Alzheimer's Disease Neuroimaging Initiative(A. D. N. I.) (2014).  Genetic modification of the relationship between phosphorylated tau and neurodegeneration. Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

[3549] Altmann, A., Tian L., Henderson V. W., Greicius M. D., & Alzheimer's Disease Neuroimaging Initiative(A. D. N. I.) (2014).  Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of Neurology. 75(4), 563 - 573.

[2907] Stein, J. L., Medland S. E., Vasquez A A., Hibar D. P., Senstad R. E., Winkler A. M., et al. (2012).  Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44(5), 552 - 561.

[2713] Vidoni, E. d, Townley R. a, Honea R. a, Burns J. m, & Alzheimer's Disease Neuroimaging Initiative(A. D. N. I.) (2011).  Alzheimer disease biomarkers are associated with body mass index. Neurology. 77(21), 1913 - 1920.

[2503] Stricker, N. H., Chang Y. - L., Fennema-Notestine C., Delano-Wood L., Salmon D. P., Bondi M. W., et al. (2011).  Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology. 77(8), 713 - 721.

[2785] Kauwe, J. S. K., Cruchaga C., Karch C. M., Sadler B., Lee M., Mayo K., et al. (2011).  Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease. PLoS ONE. 6(2), e15918 - e15918.

[2443] Brown, P. J., Devanand D. P., Liu X., Caccappolo E., & Alzheimer's Disease Neuroimaging Initiative(A. D. N. I.) (2011).  Functional Impairment in Elderly Patients With Mild Cognitive Impairment and Mild Alzheimer Disease. Arch Gen Psychiatry. 68(6), 617 - 626.

[1980] Carmichael, O., Schwarz C., Drucker D., Fletcher E., Harvey D., Beckett L., et al. (2010).  Longitudinal Changes in White Matter Disease and Cognition in the First Year of the Alzheimer Disease Neuroimaging Initiative. Arch Neurol. 67(11), 1370 - 1378.